These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18452105)

  • 1. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
    Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
    Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
    Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
    Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-CdA in the treatment of hairy cell leukaemia.
    Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
    J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
    Ferrari J; Lang W; Thurnher S; Müllauer L; Raderer M
    Neurology; 2004 Jul; 63(2):399-400. PubMed ID: 15277655
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
    Zimmer-Molsberger B; Knauf W; Thiel E
    Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
    [No Abstract]   [Full Text] [Related]  

  • 6. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
    Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
    Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
    Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
    Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
    Juliusson G; Liliemark J
    Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoma, hairy-cell leukemia respond to new agents.
    Oncology (Williston Park); 1992 Sep; 6(9):94. PubMed ID: 1449980
    [No Abstract]   [Full Text] [Related]  

  • 12. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
    Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
    Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).
    Virchis A; Mehta A
    Br J Haematol; 1998 Mar; 100(3):609. PubMed ID: 9504654
    [No Abstract]   [Full Text] [Related]  

  • 14. The tumor necrosis factor family and and correlation with disease activity and response to treatment in hairy cell leukemia.
    Barak V; Nisman B; Polliack A
    Eur J Haematol; 1999 Feb; 62(2):71-5. PubMed ID: 10052708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2-CDA in treatment of hairy cell leukemia: a comparison between intravenous and subcutaneous administration. Swiss Study Group of Applied Cancer Research].
    Sperb RA; von Rohr A; Ratschiller D; Bacchi M; Tichelli A; Hess U; Cerny T; Tobler A; Betticher DC
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1593-7. PubMed ID: 9824888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.
    Gora-Tybor J; Lech-Miranda E; Blonski JZ; Robak T
    Adv Exp Med Biol; 2000; 486():307-10. PubMed ID: 11783506
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective treatment of autoimmune hemolytic anemia and hairy cell leukemia with interferon-alpha.
    Cesana C; Brando B; Boiani E; Chiodo F; Cairoli R; Intropido L; Morra E
    Eur J Haematol; 2002 Feb; 68(2):120-1. PubMed ID: 11982619
    [No Abstract]   [Full Text] [Related]  

  • 18. Fulminant hepatitis C virus infection.
    Schirmer M; Vogel W; Thaler J; Grünewald K; Umlauft F; Geisen F; Zilian U; Konwalinka G
    Lancet; 1994 Jun; 343(8910):1433. PubMed ID: 7910911
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Juliusson G; Liliemark J
    Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of hairy cell leukemia: an update.
    Golomb HM; Ratain MJ; Mick R; Daly K
    Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.